Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Other Accumulated Expenses: 2020-2025

Historic Other Accumulated Expenses for BIO-TECHNE (TECH) over the last 5 years, with Sep 2025 value amounting to $4.5 million.

  • BIO-TECHNE's Other Accumulated Expenses rose 6.49% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 6.49%. This contributed to the annual value of $1.6 million for FY2025, which is 23.52% down from last year.
  • As of Q3 2025, BIO-TECHNE's Other Accumulated Expenses stood at $4.5 million, which was up 176.35% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Other Accumulated Expenses registered a high of $5.5 million during Q4 2021, and its lowest value of $865,000 during Q1 2023.
  • Over the past 3 years, BIO-TECHNE's median Other Accumulated Expenses value was $2.6 million (recorded in 2024), while the average stood at $2.8 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first slumped by 75.87% in 2022, then skyrocketed by 240.92% in 2024.
  • Over the past 5 years, BIO-TECHNE's Other Accumulated Expenses (Quarterly) stood at $5.5 million in 2021, then tumbled by 75.87% to $1.3 million in 2022, then skyrocketed by 220.32% to $4.2 million in 2023, then tumbled by 37.70% to $2.6 million in 2024, then grew by 6.49% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q3 2025, $1.6 million for Q2 2025, and $1.8 million during Q1 2025.